149 related articles for article (PubMed ID: 23070006)
1. Splice variants in apoptotic pathway.
Miura K; Fujibuchi W; Unno M
Exp Oncol; 2012 Oct; 34(3):212-7. PubMed ID: 23070006
[TBL] [Abstract][Full Text] [Related]
2. Role of IG20 splice variants in TRAIL resistance.
Prabhakar BS; Mulherkar N; Prasad KV
Clin Cancer Res; 2008 Jan; 14(2):347-51. PubMed ID: 18223207
[TBL] [Abstract][Full Text] [Related]
3. E2F1 controls alternative splicing pattern of genes involved in apoptosis through upregulation of the splicing factor SC35.
Merdzhanova G; Edmond V; De Seranno S; Van den Broeck A; Corcos L; Brambilla C; Brambilla E; Gazzeri S; Eymin B
Cell Death Differ; 2008 Dec; 15(12):1815-23. PubMed ID: 18806759
[TBL] [Abstract][Full Text] [Related]
4. MADD, a splice variant of IG20, is indispensable for MAPK activation and protection against apoptosis upon tumor necrosis factor-alpha treatment.
Kurada BRVVSN; Li LC; Mulherkar N; Subramanian M; Prasad KV; Prabhakar BS
J Biol Chem; 2009 May; 284(20):13533-13541. PubMed ID: 19289468
[TBL] [Abstract][Full Text] [Related]
5. BCL-XL regulates TNF-alpha-mediated cell death independently of NF-kappaB, FLIP and IAPs.
Gozzelino R; Sole C; Llecha N; Segura MF; Moubarak RS; Iglesias-Guimarais V; Perez-Garcia MJ; Reix S; Zhang J; Badiola N; Sanchis D; Rodriguez-Alvarez J; Trullas R; Yuste VJ; Comella JX
Cell Res; 2008 Oct; 18(10):1020-36. PubMed ID: 18591962
[TBL] [Abstract][Full Text] [Related]
6. Identification of a novel cis-element that regulates alternative splicing of Bcl-x pre-mRNA.
Lee J; Zhou J; Zheng X; Cho S; Moon H; Loh TJ; Jo K; Shen H
Biochem Biophys Res Commun; 2012 Apr; 420(2):467-72. PubMed ID: 22440396
[TBL] [Abstract][Full Text] [Related]
7. MADD/DENN splice variant of the IG20 gene is necessary and sufficient for cancer cell survival.
Mulherkar N; Ramaswamy M; Mordi DC; Prabhakar BS
Oncogene; 2006 Oct; 25(47):6252-61. PubMed ID: 16682944
[TBL] [Abstract][Full Text] [Related]
8. Emetine and the alternative splicing of Bcl-X: where to next?
Shultz JC; Chalfant CE
Chem Biol; 2007 Dec; 14(12):1313-4. PubMed ID: 18096499
[TBL] [Abstract][Full Text] [Related]
9. Regulation of apoptosis by alternative pre-mRNA splicing.
Schwerk C; Schulze-Osthoff K
Mol Cell; 2005 Jul; 19(1):1-13. PubMed ID: 15989960
[TBL] [Abstract][Full Text] [Related]
10. [Pre-mRNA alternative splicing in cancer: functional impact, molecular mechanisms and therapeutic perspectives].
Revil T; Shkreta L; Chabot B
Bull Cancer; 2006 Sep; 93(9):909-19. PubMed ID: 16980234
[TBL] [Abstract][Full Text] [Related]
11. Molecular cloning of novel alternatively spliced variants of BCL2L12, a new member of the BCL2 gene family, and their expression analysis in cancer cells.
Kontos CK; Scorilas A
Gene; 2012 Aug; 505(1):153-66. PubMed ID: 22664385
[TBL] [Abstract][Full Text] [Related]
12. Targeting the anti-apoptotic Bcl-2 family members for the treatment of cancer.
Weyhenmeyer B; Murphy AC; Prehn JH; Murphy BM
Exp Oncol; 2012 Oct; 34(3):192-9. PubMed ID: 23070004
[TBL] [Abstract][Full Text] [Related]
13. Survivin 2alpha: a novel Survivin splice variant expressed in human malignancies.
Caldas H; Honsey LE; Altura RA
Mol Cancer; 2005 Mar; 4(1):11. PubMed ID: 15743529
[TBL] [Abstract][Full Text] [Related]
14. IG20, a MADD splice variant, increases cell susceptibility to gamma-irradiation and induces soluble mediators that suppress tumor cell growth.
Efimova E; Martinez O; Lokshin A; Arima T; Prabhakar BS
Cancer Res; 2003 Dec; 63(24):8768-76. PubMed ID: 14695193
[TBL] [Abstract][Full Text] [Related]
15. Modification of alternative splicing of Bcl-x pre-mRNA in prostate and breast cancer cells. analysis of apoptosis and cell death.
Mercatante DR; Bortner CD; Cidlowski JA; Kole R
J Biol Chem; 2001 May; 276(19):16411-7. PubMed ID: 11278482
[TBL] [Abstract][Full Text] [Related]
16. Splice isoforms as therapeutic targets for colorectal cancer.
Miura K; Fujibuchi W; Unno M
Carcinogenesis; 2012 Dec; 33(12):2311-9. PubMed ID: 23118106
[TBL] [Abstract][Full Text] [Related]
17. Role of death receptor and mitochondrial pathways in conventional chemotherapy drug induction of apoptosis.
Wang P; Song JH; Song DK; Zhang J; Hao C
Cell Signal; 2006 Sep; 18(9):1528-35. PubMed ID: 16442262
[TBL] [Abstract][Full Text] [Related]
18. Caspases and cancer: mechanisms of inactivation and new treatment modalities.
Philchenkov A; Zavelevich M; Kroczak TJ; Los M
Exp Oncol; 2004 Jun; 26(2):82-97. PubMed ID: 15273659
[TBL] [Abstract][Full Text] [Related]
19. Genomic structure, alternative splicing and tissue expression of rFrp/sFRP-4, the rat frizzled related protein gene.
Yam JW; Chan KW; Ngan ES; Hsiao WL
Gene; 2005 Aug; 357(1):55-62. PubMed ID: 16005582
[TBL] [Abstract][Full Text] [Related]
20. Differential Impacts of Alternative Splicing Networks on Apoptosis.
Lin JC; Tsao MF; Lin YJ
Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27983653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
